Subclinical hypothyroidism and the risk of stroke events and fatal stroke: An individual participant data analysis

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 6, 2015, Pages 2181-2191

  Chaker, Layal ^a   Baumgartner, Christine ^b   Den Elzen, Wendy P J ^c   Ikram, M Arfan ^a   Blum, Manuel R ^b   Collet, Tinh Hai ^d   Bakker, Stephan J L ^e   Dehghan, Abbas ^a   Drechsler, Christiane ^f   Luben, Robert N ^g   Hofman, Albert ^a   Portegies, Marileen L P ^a   Medici, Marco ^a   Iervasi, Giorgio ^h   Stott, David J ⁱ   Ford, Ian ^j   Bremner, Alexandra ^k   Wanner, Christoph ^f   Ferrucci, Luigi ^l   Newman, Anne B ^m   Dullaart, Robin P ^e   Sgarbi, José A ^n,o   Ceresini, Graziano ^p   Maciel, Rui M B ^o   Westendorp, Rudi G ^q   Jukema, J Wouter ^c,r   Imaizumi, Misa ^s   Franklyn, Jayne A ^t   Bauer, Douglas C ^u   Walsh, John P ^v,w   Razvi, Salman ^x   Khaw, Kay Tee ^g   Cappola, Anne R ^y   Völzke, Henry ^z   Franco, Oscar H ^a   Gussekloo, Jacobijn ^c   Rodondi, Nicolas ^b   Peeters, Robin P ^a   more..

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF BERN   (Switzerland)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^e UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^f UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^g UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^h INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

ⁱ UNIVERSITY OF GLASGOW   (United Kingdom)

^j UNIVERSITY OF GLASGOW   (United Kingdom)

^k UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^l NATIONAL INSTITUTE ON AGING   (United States)

^m UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

ⁿ FACULDADE DE MEDICINA DE MARÍLIA   (Brazil)

^o FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^p UNIVERSITY OF PARMA   (Italy)

^q UNIVERSITY OF COPENHAGEN   (Denmark)

^r ROYAL NETHERLANDS ACADEMY OF ARTS AND SCIENCES   (Netherlands)

^s RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^t UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^u UNIVERSITY OF CALIFORNIA   (United States)

^v SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^w UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^x GATESHEAD HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^y UNIVERSITY OF PENNSYLVANIA   (United States)

^z UNIVERSITY MEDICINE GREIFSWALD   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; THYROTROPIN;

AGE; AGE DISTRIBUTION; ARTICLE; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; DISEASE ASSOCIATION; EUTHYROIDISM; FATALITY; HEART FAILURE; HUMAN; ISCHEMIC HEART DISEASE; LONGITUDINAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SUBCLINICAL HYPOTHYROIDISM; SYSTEMATIC REVIEW; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; ADULT; ASYMPTOMATIC DISEASE; BLOOD; COMPLICATION; FEMALE; HYPOTHYROIDISM; INCIDENCE; MALE; MORTALITY; RISK FACTOR; STROKE;

ADULT; ASYMPTOMATIC DISEASES; FEMALE; HUMANS; HYPOTHYROIDISM; INCIDENCE; MALE; RISK FACTORS; STROKE; THYROTROPIN;

EID: 84930796300     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2015-1438     Document Type: Article

References (69)

1. Surks MI, Ortiz E, Daniels GH, et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA. 2004;291:228-238.
2. Gharib H, Tuttle RM, Baskin HJ, Fish LH, Singer PA, McDermott MT. Subclinical thyroid dysfunction: a joint statement on management from the American Association of Clinical Endocrinologists, the American Thyroid Association, and The Endocrine Society. J Clin Endocrinol Metab. 2005;90:581-585; discussion 586-587.
3. Helfand M, U.S. Preventive Services Task Force. Screening for subclinical thyroid dysfunction in nonpregnant adults: a summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med. 2004;140:128-141.
4. Aghini-Lombardi F, Antonangeli L, Martino E, et al. The spectrum of thyroid disorders in an iodine-deficient community: the Pescopagano survey. J Clin Endocrinol Metab. 1999;84:561-566.
5. Aoki Y, Belin RM, Clickner R, Jeffries R, Phillips L, Mahaffey KR. Serum TSH and total T4 in the United States population and their association with participant characteristics: National Health and Nutrition Examination Survey (NHANES 1999-2002). Thyroid. 2007;17:1211-1223.
6. Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med. 2000;160:526-534.
7. Teng W, Shan Z, Teng X, et al. Effect of iodine intake on thyroid diseases in China. N Engl J Med. 2006;354:2783-2793.
8. Bauer DC, Ettinger B, Browner WS. Thyroid functions and serum lipids in older women: a population-based study. Am J Med. 1998;104:546-551.
9. Biondi B. Cardiovascular effects of mild hypothyroidism. Thyroid. 2007;17:625-630.
10. Hak AE, Pols HA, Visser TJ, Drexhage HA, Hofman A, Witteman JC. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann Intern Med. 2000;132:270-278.
11. Gao N, Zhang W, Zhang YZ, Yang Q, Chen SH. Carotid intimamedia thickness in patients with subclinical hypothyroidism: a metaanalysis. Atherosclerosis. 2013;227:18-25.
12. Rodondi N, den Elzen WP, Bauer DC, et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA. 2010;304:1365-1374.
13. Gencer B, Collet TH, Virgini V, et al. Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts. Circulation. 2012;126:1040-1049.
14. Razvi S, Shakoor A, Vanderpump M, Weaver JU, Pearce SH. The influence of age on the relationship between subclinical hypothyroidism and ischemic heart disease: a metaanalysis. J Clin Endocrinol Metab. 2008;93:2998-3007.
15. Gussekloo J, van Exel E, de Craen AJ, Meinders AE, Frölich M, Westendorp RG. Thyroid status, disability and cognitive function, and survival in old age. JAMA. 2004;292:2591-2599.
16. Chaker L, Baumgartner C, Ikram MA, et al. Subclinical thyroid dysfunction and the risk of stroke: a systematic review and metaanalysis. Eur J Epidemiol. 2014;29:791-800.
17. Cappola AR, Fried LP, Arnold AM, et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA. 2006;295:1033-1041.
18. Imaizumi M, Akahoshi M, Ichimaru S, et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J Clin Endocrinol Metab. 2004;89:3365-3370.
19. Rodondi N, Newman AB, Vittinghoff E, et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch Intern Med. 2005;165:2460-2466.
20. Drechsler C, Schneider A, Gutjahr-Lengsfeld L, et al. Thyroid function, cardiovascular events, and mortality in diabetic hemodialysis patients. Am J Kidney Dis. 2014;63:988-996.
21. Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet. 2001;358:861-865.
22. Schultz M, Kistorp C, Raymond I, et al. Cardiovascular events in thyroid disease: a population based, prospective study. Horm Metab Res. 2011;43:653-659.
23. Hillege HL, Janssen WM, Bak AA, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med. 2001;249:519-526.
24. Völzke H, Alte D, Schmidt CO, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40:294-307.
25. Walsh JP, Bremner AP, Bulsara MK, et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005;165:2467-2472.
26. Collet TH, Gussekloo J, Bauer DC, et al. Subclinical hyperthyroidism and the risk of coronary heart disease and mortality. Arch Intern Med. 2012;172:799-809.
27. Boekholdt SM, Titan SM, Wiersinga WM, et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin Endocrinol (Oxf). 2010;72:404-410.
28. Nicoloff JT, Spencer CA. Clinical review 12: the use and misuse of the sensitive thyrotropin assays. J Clin Endocrinol Metab. 1990;71:553-558.
29. Razvi S, Weaver JU, Vanderpump MP, Pearce SH. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J Clin Endocrinol Metab. 2010;95:1734-1740.
30. Hollowell JG, Staehling NW, Flanders WD, et al. Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III). J Clin Endocrinol Metab. 2002;87:489-499.
31. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
32. Higgins JP, Thompson SG. Quantifying heterogeneity in a metaanalysis. Stat Med. 2002;21:1539-1558.
33. Firth D. Bias reduction of maximum likelihood estimates. Biometrika. 1993;80:27-38.
34. Heinze G, Schemper M. A solution to the problem of monotone likelihood in Cox regression. Biometrics. 2001;57:114-119.
35. Waring AC, Harrison S, Samuels MH, et al. Thyroid function and mortality in older men: a prospective study. J Clin Endocrinol Metab. 2012;97:862-870.
36. Egger M, Davey Smith G, Schneider M, Minder C. Bias in metaanalysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
37. Ferrucci L, Bandinelli S, Benvenuti E, et al. Subsystems contributing to the decline in ability to walk: bridging the gap between epidemiology and geriatric practice in the InCHIANTI study. J Am Geriatr Soc. 2000;48:1618-1625.
38. Hofman A, Darwish Murad S, van Duijn CM, et al. The Rotterdam Study: 2014 objectives and design update. Eur J Epidemiol. 2013;28:889-926.
39. Iervasi G, Molinaro S, Landi P, et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch Intern Med. 2007;167:1526-1532.
40. Nanchen D, Gussekloo J, Westendorp RG, et al. Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk. J Clin Endocrinol Metab. 2012;97:852-861.
41. Sgarbi JA, Matsumura LK, Kasamatsu TS, Ferreira SR, Maciel RM. Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study. Eur J Endocrinol. 2010;162:569-577.
42. Iacoviello M, Guida P, Guastamacchia E, et al. Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients. Curr Pharm Des. 2008;14:2686-2692.
43. Blank JB, Cawthon PM, Carrion-Petersen ML, et al. Overview of recruitment for the osteoporotic fractures in men study (MrOS). Contemp Clin Trials. 2005;26:557-568.
44. Orwoll E, Blank JB, Barrett-Connor E, et al. Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study-a large observational study of the determinants of fracture in older men. Contemp Clin Trials. 2005;26:569-585.
45. Klein I, Ojamaa K. Thyroid hormone: targeting the vascular smooth muscle cell. Circ Res. 2001;88:260-261.
46. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med. 2001;344:501-509.
47. Nagasaki T, Inaba M, Kumeda Y, et al. Increased pulse wave velocity in subclinical hypothyroidism. J Clin Endocrinol Metab. 2006;91:154-158.
48. Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12:287-293.
49. Cappola AR, Ladenson PW. Hypothyroidism and atherosclerosis. J Clin Endocrinol Metab. 2003;88:2438-2444.
50. Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev. 2008;29:76-131.
51. Erem C. Coagulation and fibrinolysis in thyroid dysfunction. Endocrine. 2009;36:110-118.
52. Erem C, Kavgaci H, Ersöz HO, et al. Blood coagulation and fibrinolytic activity in hypothyroidism. Int J Clin Pract. 2003;57:78-81.
53. Guldiken S, Demir M, Turgut B, Altun BU, Arikan E, Kara M. Global fibrinolytic capacity in patients with subclinical hypothyroidism. Endocr J. 2005;52:363-367.
54. Jorde R, Figenschau Y, Hansen JB. Haemostatic function in subjects with mild subclinical hypothyroidism. The Tromsø study. Thromb Haemost. 2006;95:750-751.
55. Cantürk Z, Cetinarslan B, Tarkun I, Cantürk NZ, Ozden M, Duman C. Hemostatic system as a risk factor for cardiovascular disease in women with subclinical hypothyroidism. Thyroid. 2003;13:971-977.
56. Wiman B, Andersson T, Hallqvist J, Reuterwall C, Ahlbom A, de-Faire U. Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study. Arterioscler Thromb Vasc Biol. 2000;20:2019-2023.
57. Ochs N, Auer R, Bauer DC, et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann Intern Med. 2008;148:832-845.
58. Razvi S, Ingoe LE, McMillan CV, Weaver JU. Health status in patients with sub-clinical hypothyroidism. Eur J Endocrinol. 2005;152:713-717.
59. Kim B. Thyroid hormone as a determinant of energy expenditure and the basal metabolic rate. Thyroid. 2008;18:141-144.
60. Silva JE, Bianco SD. Thyroid-adrenergic interactions: physiological and clinical implications. Thyroid. 2008;18:157-165.
61. Singhal AB, Biller J, Elkind MS, et al. Recognition and management of stroke in young adults and adolescents. Neurology. 2013;81:1089-1097.
62. Putter H, Fiocco M, Geskus RB. Tutorial in biostatistics: competing risks and multi-state models. Stat Med. 2007;26:2389-2430.
63. Surks MI, Hollowell JG. Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism. J Clin Endocrinol Metab. 2007;92:4575-4582.
64. Pearce SHS, Brabant G, Duntas LH, et al. 2013 ETA guideline: management of subclinical hypothyroidism. Eur Thyroid J. 2013;2:215-228.
65. Lewis GF, Alessi CA, Imperial JG, Refetoff S. Low serum free thyroxine index in ambulating elderly is due to a resetting of the threshold of thyrotropin feedback suppression. J Clin Endocrinol Metab. 1991;73:843-849.
66. Bremner AP, Feddema P, Leedman PJ, et al. Age-related changes in thyroid function: a longitudinal study of a community-based cohort. J Clin Endocrinol Metab. 2012;97:1554-1562.
67. Waring AC, Arnold AM, Newman AB, Búzková P, Hirsch C, Cappola AR. Longitudinal changes in thyroid function in the oldest old and survival: the Cardiovascular Health Study All-Stars Study. J Clin Endocrinol Metab. 2012;97:3944-3950.
68. Vadiveloo T, Donnan PT, Murphy MJ, Leese GP. Age- and gender-specific TSH reference intervals in people with no obvious thyroid disease in Tayside, Scotland: the Thyroid Epidemiology, Audit, and Research Study (TEARS). J Clin Endocrinol Metab. 2013;98:1147-1153.
69. Kahapola-Arachchige KM, Hadlow N, Wardrop R, Lim EM, Walsh JP. Age-specific TSH reference ranges have minimal impact on the diagnosis of thyroid dysfunction. Clin Endocrinol (Oxf). 2012;77:773-779.